Cation leak through the ATP1A3 pump causes spasticity and intellectual disability.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 08 2023
Historique:
received: 29 08 2022
revised: 09 02 2023
accepted: 28 02 2023
medline: 3 8 2023
pubmed: 13 4 2023
entrez: 12 4 2023
Statut: ppublish

Résumé

ATP1A3 encodes the α3 subunit of the sodium-potassium ATPase, one of two isoforms responsible for powering electrochemical gradients in neurons. Heterozygous pathogenic ATP1A3 variants produce several distinct neurological syndromes, yet the molecular basis for phenotypic variability is unclear. We report a novel recurrent variant, ATP1A3(NM_152296.5):c.2324C>T; p.(Pro775Leu), in nine individuals associated with the primary clinical features of progressive or non-progressive spasticity and developmental delay/intellectual disability. No patients fulfil diagnostic criteria for ATP1A3-associated syndromes, including alternating hemiplegia of childhood, rapid-onset dystonia-parkinsonism or cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss (CAPOS), and none were suspected of having an ATP1A3-related disorder. Uniquely among known ATP1A3 variants, P775L causes leakage of sodium ions and protons into the cell, associated with impaired sodium binding/occlusion kinetics favouring states with fewer bound ions. These phenotypic and electrophysiologic studies demonstrate that ATP1A3:c.2324C>T; p.(Pro775Leu) results in mild ATP1A3-related phenotypes resembling complex hereditary spastic paraplegia or idiopathic spastic cerebral palsy. Cation leak provides a molecular explanation for this genotype-phenotype correlation, adding another mechanism to further explain phenotypic variability and highlighting the importance of biophysical properties beyond ion transport rate in ion transport diseases.

Identifiants

pubmed: 37043503
pii: 7116208
doi: 10.1093/brain/awad124
pmc: PMC10393399
doi:

Substances chimiques

Cations 0
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13
ATP1A3 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3162-3171

Subventions

Organisme : NIGMS NIH HHS
ID : T32 GM007526
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103538
Pays : United States
Organisme : NINDS NIH HHS
ID : R35 NS105078
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NINDS NIH HHS
ID : T32 NS043124
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG011758
Pays : United States

Informations de copyright

Published by Oxford University Press on behalf of the Guarantors of Brain 2023.

Références

Lancet Neurol. 2012 Sep;11(9):764-73
pubmed: 22850527
Neuron. 2004 Jul 22;43(2):169-75
pubmed: 15260953
J Gen Physiol. 2004 Apr;123(4):357-76
pubmed: 15024043
Neurol Genet. 2020 Aug 04;6(5):e466
pubmed: 32802951
Sci Adv. 2021 Mar 24;7(13):
pubmed: 33762331
J Neurophysiol. 2004 Feb;91(2):767-83
pubmed: 14762149
Front Physiol. 2017 Jun 06;8:371
pubmed: 28634454
Neurobiol Dis. 2015 May;77:88-93
pubmed: 25681536
Neurobiol Dis. 2020 Sep;143:105012
pubmed: 32653672
Orphanet J Rare Dis. 2014 Jan 28;9:15
pubmed: 24468074
Eur J Paediatr Neurol. 2021 May;32:A4-A5
pubmed: 33975787
Nat Genet. 2013 Sep;45(9):1055-60
pubmed: 23913004
Am J Hum Genet. 2018 Nov 1;103(5):808-816
pubmed: 30388404
Brain. 2021 Jun 22;144(5):1435-1450
pubmed: 33880529
Pediatr Neurol. 2000 Aug;23(2):134-41
pubmed: 11020638
Parkinsonism Relat Disord. 2020 Sep;78:189-191
pubmed: 32684337
Nat Genet. 2012 Sep;44(9):1030-4
pubmed: 22842232
Brief Bioinform. 2011 Jan;12(1):41-51
pubmed: 21278375
Dev Med Child Neurol. 2021 Jan;63(1):111-115
pubmed: 32895939
Nature. 2013 Oct 10;502(7470):201-6
pubmed: 24089211
Nat Genet. 2014 Feb;46(2):144-51
pubmed: 24336169
Nature. 2000 Feb 24;403(6772):898-901
pubmed: 10706288
J Gen Physiol. 2014 Apr;143(4):449-64
pubmed: 24688018
Neurobiol Dis. 2018 Jul;115:29-38
pubmed: 29567111
J Comp Neurol. 2022 Feb;530(3):627-647
pubmed: 34415061
Neurobiol Dis. 2019 Dec;132:104577
pubmed: 31425744
Am J Hum Genet. 2016 Oct 6;99(4):877-885
pubmed: 27666373
Neurol Genet. 2017 Mar 02;3(2):e139
pubmed: 28293679
J Gen Physiol. 2017 Nov 6;149(11):1009-1028
pubmed: 29030398
Genome Med. 2021 Feb 22;13(1):31
pubmed: 33618777
J Biol Chem. 2019 Jan 4;294(1):269-280
pubmed: 30409907

Auteurs

Daniel G Calame (DG)

Section of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Texas Children's Hospital, Houston, TX 77030, USA.

Cristina Moreno Vadillo (C)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Seth Berger (S)

Children's National Rare Disease Institute, Children's National Hospital, Washington, DC 20012, USA.

Timothy Lotze (T)

Section of Pediatric Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
Texas Children's Hospital, Houston, TX 77030, USA.

Marwan Shinawi (M)

Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Javaher Poupak (J)

Zentrum Für Labormedizin, St. Gallen 9001, Switzerland.

Corina Heller (C)

Praxis Für Humangenetik Tübingen, Tuebingen 72076, Germany.
CeGaT GmbH, Tuebingen 72076, Germany.

Julie Cohen (J)

Department of Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Richard Person (R)

GeneDX, Gaithersburg, MD 20879, USA.

Aida Telegrafi (A)

GeneDX, Gaithersburg, MD 20879, USA.

Chalongchai Phitsanuwong (C)

Section of Pediatric Neurology, Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, IL 60637, USA.

Kaylene Fiala (K)

Section of Pediatric Neurology, Department of Pediatrics, Comer Children's Hospital, University of Chicago, Chicago, IL 60637, USA.

Isabelle Thiffault (I)

Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
School of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA.
Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO 64108, USA.

Florencia Del Viso (F)

Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
Department of Pathology and Laboratory Medicine, Children's Mercy Hospital, Kansas City, MO 64108, USA.

Dihong Zhou (D)

School of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA.
Department of Genetics, Children's Mercy Hospital, Kansas City, MO 64108, USA.

Emily A Fleming (EA)

Department of Genetics, Children's Mercy Hospital, Kansas City, MO 64108, USA.

Tomi Pastinen (T)

Genomic Medicine Center, Children's Mercy Research Institute, Kansas City, MO 64108, USA.
School of Medicine, University of Missouri Kansas City, Kansas City, MO 64108, USA.

Ali Fatemi (A)

Department of Neurology and Developmental Medicine, Kennedy Krieger Institute, Baltimore, MD 21205, USA.
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Sruthi Thomas (S)

Departments of Physical Medicine & Rehabilitation and Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.

Samuel I Pascual (SI)

Department of Pediatric Neurology, La Paz University Hospital, Madrid, Spain.

Rosa J Torres (RJ)

La Paz University Hospital Health Research Institute (FIBHULP), IdiPaz, Madrid, Spain.
Center for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, 20829 Madrid, Spain.

Carmen Prior (C)

Department of Genetics, Genetic Service, La Paz University Hospital, Madrid, Spain.

Clara Gómez-González (C)

Department of Genetics, Genetic Service, La Paz University Hospital, Madrid, Spain.

Saskia Biskup (S)

Praxis Für Humangenetik Tübingen, Tuebingen 72076, Germany.
CeGaT GmbH, Tuebingen 72076, Germany.

James R Lupski (JR)

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Texas Children's Hospital, Houston, TX 77030, USA.
Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.

Dragan Maric (D)

Flow and Imaging Cytometry Core Facility, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Miguel Holmgren (M)

National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.

Debra Regier (D)

Children's National Rare Disease Institute, Children's National Hospital, Washington, DC 20012, USA.

Sho T Yano (ST)

National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH